All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 18 points (0.1%) at 15,482 as of Monday, July 15, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,893 issues advancing vs. 1,042 declining with 108 unchanged. The Drugs industry currently sits up 0.6% versus the S&P 500, which is up 0.1%. A company within the industry that fell today was Novo Nordisk A/S ( NVO), up 0.7%. TheStreet would like to highlight 5 stocks pushing the industry higher today: 5. Idexx Laboratories ( IDXX) is one of the companies pushing the Drugs industry higher today. As of noon trading, Idexx Laboratories is up $2.48 (2.6%) to $96.37 on heavy volume. Thus far, 406,641 shares of Idexx Laboratories exchanged hands as compared to its average daily volume of 526,300 shares. The stock has ranged in price between $95.60-$96.97 after having opened the day at $95.60 as compared to the previous trading day's close of $93.89. IDEXX Laboratories, Inc. develops, manufactures, and distributes various products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. Idexx Laboratories has a market cap of $5.0 billion and is part of the health care sector. Shares are up 0.5% year to date as of the close of trading on Friday. Currently there are 3 analysts that rate Idexx Laboratories a buy, 1 analyst rates it a sell, and 5 rate it a hold. TheStreet Ratings rates Idexx Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Idexx Laboratories Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.